Inhale and Eli Lilly Forteo development program

INHL reinitiated a 1997 development program with LLY for pulmonary delivery of LLY's Forteo recombinant parathyroid hormone osteoporosis therapy using INHL's Inhance drug delivery platform and Solo in...